Tag
Swapan Khandelwal
2 articles
Goldline Pharma FY26 Net Profit Up 45% to ₹4.12 Cr
Goldline Pharmaceutical Limited submitted its Annual Report for FY 2025-26, reporting a 45% increase in net profit to ₹4.12 crore and revenue growth to ₹31.20 crore.
The company successfully listed on
Goldline Pharma Promoter Acquires 60,000 Shares
Goldline Pharmaceutical Ltd discloses promoter Swapan Khandelwal's open market purchase of 60,000 equity shares.
The acquisition represents 0.62% of total paid-up capital, increasing his holding from